跳至主要内容
临床试验/NCT01878916
NCT01878916已完成不适用

Plasma Cobalamin, Folate, Pyridoxine and Homocysteine Levels and Thrombosis in Patients With Philadelphia-chromosome-negative Myeloproliferative Neoplasms

Istanbul University1 个研究点 分布在 1 个国家开始时间: 2003年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
试验地点
1
主要终点
Thrombosis

研究概览

简要总结

Hyperhomocysteinemia is a risk for thrombosis. Thrombosis is more frequent in myeloproliferative neoplasms (MPNs) than the normal population. In this study, we investigated the thrombosis incidence, the effects of plasma homocysteine levels on thrombosis, and the correlations between folate, cobalamin, pyridoxine and homocysteine levels in MPNs, and to compare these results with the healthy controls.

详细描述

Thirty-one new or formerly diagnosed MPN patients who consecutively visitted our outpatient clinic, as well as 40 age and sex matched healthy controls were enrolled in this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult MPN patients and healthy controls who gave a written consent were included in the study.

排除标准

  • Exclusion criteria included not giving a written consent and using medications without an indication which may have an effect on plasma homocysteine and vitamin levels.

结局指标

主要结局

Thrombosis

时间窗: at least 1 year

次要结局

  • High Hcy level(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. A. Emre Eşkazan

MD

Istanbul University

研究点 (1)

Loading locations...

相似试验